Copyright
©The Author(s) 2016.
World J Gastrointest Surg. Jan 27, 2016; 8(1): 5-26
Published online Jan 27, 2016. doi: 10.4240/wjgs.v8.i1.5
Published online Jan 27, 2016. doi: 10.4240/wjgs.v8.i1.5
Knowledge of caudal view anatomy |
Training in cadaveric and/or animal model |
Clinical training should follow an increasing order of procedure difficulty (Difficult Scoring System for LLR[78] can be used to point difficulty levels) |
Minor anterolateral resections |
Minor anatomical resections (start with LLS) |
Difficult resections |
Major resections |
Graft harvesting for LDLT |
HALS and hybrid resections can be used in the early experience to overcome the learning curve |
Ref. | Cases | Malignancy | Minimally invasive approach (%) | Major resections | Conversion | Operative time | Blood loss | Transfusion | LOS | Complication | Mortality | ||
(n) | (%) | PLLR | HALS | Hybrid | (%) | (%) | (median/mean, min) | (median/mean, mL) | (%) | (median/mean, d) | (%) | (%) | |
Koffron et al[13] | 300 | 34 | 80.3 | 10.6 | 9 | 39 | 7.3 | 99 | 102 | 0.6 | 1.9 | 9.3 | 0 |
Buell et al[165] | 306 | 42 | NR | NR | NR | 45 | 2.4 | 162 | 222 | 7 | 2.9 | 16 | 1.6 |
Bryant et al[163] | 166 | 60 | 95.2 | 4.8 | 0 | 18.6 | 9.6 | 180 | 329 | 5.4 | 6 | 15.1 | 0 |
Long et al[164] | 173 | 100 (HCC) | 100 | 0 | 0 | 8.3 | 2.3 | 112 | 194 | NR | 6.5 | 2.4 | 0 |
Cai et al[81] | 365 | 27.1 | 100 | 0 | 0 | 22.2 | 17.2 | 150 | 370 | NR | 9.2 | 12.2 | 0 |
Gobardhan et al[93] | 476 | 79 | NR | NR | NR | 33.8 | 4.2 | NA | NA | 4.6 | NR | 21 | 0.8 |
Troisi et al[99] | 265 | 64.1 | 99.3 | 0 | 0.7 | 17.4 | 6.4 | 254 | 171 | NR | 5.5 | 14 | 0 |
University of Sao Paulo series 2015 | 214 | 65.9 | 75.2 | 5.6 | 19.2 | 14.5 | 6.5 | 205 | 240 | 7.4 | 4.5 | 15 | 0.5 |
Ref. | Cases (n) | Type of study | Major hepatectomies (%) | Conversion (%) | Transfusion (%) | Complication (%) | Mortality (%) |
Katkhouda et al[28] | 121 | Retrospective | 0 | 8.3 | 0 | 0 | 0 |
Descottes et al[12] | 87 | Retrospective multicenter | 3.4 | 10 | 6 | 5 | 0 |
Ardito et al[29] | 50 | Retrospective | 16 | 8 | 2 | 10 | 0 |
Troisi et al[30] | 20 | Comparative (LLR × OLR) | 2.5 | 10 | 10 | 20 | 0 |
Abu Hilal et al[32] | 50 | Retrospective | 28 | 2 | 2 | 7 | 0 |
Abu Hilal et al[31] | 13 HA only | Retrospective | 62 | 0 | 7.7 | 7.7 | 0 |
Herman et al[17] | 31 HA only | Retrospective | 16.7 | 0 | 0 | 6.5 | 0 |
de'Angelis et al[197] | 36 HA only | Comparative (LLR × OLR) | 25 | 8.3 | 0 | 8.3 | 0 |
Dokmak et al[33] | 31 LLS only | Comparative LLS (LLR × OLR) | 0 | 6.5 | NR | 9.7 | 0 |
Ding et al[25] | 49 hepatolithiasis only underwent LLS | Prospective randomized trial (LLR × OLR) | 0 | 4.1 | NR | 6.1 | 0 |
University of Sao Paulo series 2015 | 73 | 15.1 | 0 | 4.1 | 6.9 | 0 |
Ref. | No. of patients | Blood loss (mean/median, mL) | Blood transfusion (%) | Conversion (%) | Complication (%) | Perioperative mortality (%) | 5-yr overall survival (%) | 5-yr recurrence free survival (%) | |||||||||||||
LLR | OLR | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | ||
Belli et al[34] | 54 | 125 | 297 | 580 | < 0.01 | 11 | 25.6 | 0.03 | 7 | 19 | 36 | 0.02 | 2 | 4 | NS | 671 | - | NS | 521 | - | NS |
Tranchart et al[35] | 42 | 42 | 364 | 723 | < 0.0001 | 9.5 | 16.7 | NS | 4.7 | 21.4 | 40.5 | NS | 2.4 | 2.4 | NS | 59.51 | 47.41 | NS | 60.91 | 54.31 | NS |
Truant et al[36] | 36 | 61 | 452 | 447 | NS | 2.8 | 3.8 | NS | 19.4 | 25 | 35.8 | NS | 0 | 7.5 | NS | 70 | 46 | NS | 35.5 | 33.6 | NS |
Lee et al[37] | 33 | 50 | 150 | 240 | NS | 6.1 | 10 | NS | 18.2 | 6.1 | 24 | 0.033 | 0 | 0 | NS | 76 | 76.1 | NS | 45.3 | 55.9 | NS |
Hu et al[110] | 30 | 30 | 520 g | 480 g | NS | NA | NA | - | 0 | 13.3 | 10 | NS | 0 | 0 | NS | 50 | 50.3 | NS | NR | NR | - |
Ker et al[38] | 116 | 208 | 139 | 1147 | < 0.001 | 6.9 | 50.9 | < 0.001 | 5.2 | 6 | 30.2 | < 0.001 | 0 | 2.9 | NS | 62.2 | 71.8 | NS | NR | NR | - |
Cheung et al[39] | 32 | 64 | 150 | 300 | 0.001 | 0 | 4.7 | NS | NR | 6.3 | 18.8 | NS | 0 | 1.6 | NS | 76.6 | 57 | NS | 54.5 | 44.3 | NS |
Ai et al[40] | 97 | 178 | 460 | 454 | NS | 4.6 | 2.8 | NS | 9.28 | 9 | 30 | 0.001 | 0 | 0 | NS | 861 | 881 | NS | 661 | 671 | NS |
Memeo et al[41] | 45 | 45 | 200 | 200 | NS | 0 | 0 | NS | NR | 20 | 45 | 0.01 | 2 | 13 | 0.04 | 59 | 44 | NS | 19 | 23 | NS |
Kim et al[42] | 70 | 70 | NA | NA | - | 24.3 | 40.8 | 0.001 | 8.57 | 7.1 | 14.5 | NS | NR | NR | - | 65.3 | 65.7 | NS | 58.3 | 62.6 | NS |
Kim et al[198] | 43 | 162 | 484 | 261 | NS | 3.4 | 0 | NS | 23.3 | 13.8 | 37.9 | NS | 0 | 0 | NS | 92.2 | 87.7 | NS | 54 | 40.1 | NS |
Ahn et al[43] | 51 | 51 | 350 | 355.2 | NS | 5.9 | 9.8 | NS | Excluded | 5.8 | 9.8 | NR | 0 | 0 | NS | 80.1 | 85.7 | NS | 67.8 | 54.8 | NS |
Yamashita et al[44] | 63 | 99 | 455 | 436 | NS | 6 | 2 | NS | NA | 10 | 26 | 0.046 | 0 | 0 | NS | 69 | 77 | NS | 33 | 41 | NS |
Yoon et al[45] | 58 | 174 | NA | NA | - | 3.4 | 7.5 | 0.04 | 0 | 6.9 | 22.4 | 0.02 | NR | NR | - | 882 | 682 | NS | 562 | 622 | NS |
Martin et al[46] | 100 | 254 | 336 | 755 | < 0.001 | 1.2 | 2.4 | 0.043 | NR | 44 | 57 | NS | 6 | 8 | NS | 60.71 | 41.81 | NS | 201 | 261 | NS |
Lee et al[47] | 43 | 86 | 300 | 700 | 0.004 | NR | NR | - | 14 | 23.3 | 39.5 | NS | NR | NR | - | 89.7 | 87.3 | NS | 53.5 | 58.6 | NS |
Han et al[48] | 88 | 88 | 500 | 525 | NS | 20 | 26.1 | NS | 9.1 | 12.5 | 20.4 | 0.042 | 1.1 | 1.1 | NS | 76.4 | 73.2 | NS | 44.2 | 41.2 | NS |
Xiao et al[49] | 41 | 86 | 272.2 | 170.8 | 0.001 | 7.3 | 13.9 | NS | 7.32 | 17.1 | 37.3 | 0.021 | 0 | 0 | NS | 781 | 76.71 | NS | 70.71 | 68.61 | NS |
Ref. | No. of patients | Blood loss (mean/median, mL) | Blood transfusion (%) | Conversion (%) | Complication (% ) | Perioperative mortality (%) | 5-yr overall survival (%) | 5-yr recurrence free survival (%) | |||||||||||||
LLR | OLR | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | LLR | OLR | P value | ||
Castaing et al[50] | 60 | 60 | NR | NR | - | 15 | 36 | 0.007 | 10 | 27 | 28 | NS | 1.7 | 1.7 | NS | 64 | 56 | NS | 30 | 20 | NS |
Abu Hilal et al[51] | 55 | 119 | 363 | 500 | NR | 3.6 | NR | NR | 12 | 15 | 20.2 | NR | 0 | 2 | NR | NR | NR | NR | NR | NR | - |
Cannon et al[52] | 35 | 140 | 202 | 392 | < 0.001 | 17 | 25 | NS | NR | 23 | 50 | 0.004 | 0 | 1.4 | NS | 36 | 42 | NS | 15 | 22 | NS |
Qiu et al[53] | 30 | 140 | 215 | 390 | < 0.001 | 10 | 25 | < 0.05 | 6.6 | 26.2 | 55 | < 0.001 | 0 | 0 | NS | NR | NR | - | NR | NR | - |
Guerron et al[54] | 40 | 40 | 376 | 753 | 0.041 | 5 | 20 | 0.04 | 5 | 15 | 20 | NS | 0 | 0 | NS | NR | NR | NS | NR | NR | NS |
Kubota et al[55] | 43 | 62 | 287.3 | 579.3 | < 0.001 | 2.4 | 21 | 0.004 | NR | 2.4 | 9.7 | NS | 0 | 0 | NS | 88.41 | 74.21 | NS1 | NR | NR | - |
Montalti et al[56] | 57 | 57 | 454.2 | 691.5 | 0.003 | NR | NR | - | 15.8 | 15.8 | 31.6 | 0.03 | 0 | 0 | NS | 60 | 65 | NS | 29 | 38 | NS |
de'Angelis et al[57] | 52 | 52 | 200 | 300 | 0.001 | 5.8 | 21.2 | NS | 5.8 | 17.3 | 22 | NS | 0 | 3.8 | NS | 73.1 | 62.5 | NS | 21.1 | 21.1 | NS |
Hasegawa et al[58] | 102 | 69 | 127 | 620 | 0.000 | NR | NR | NR | 1 | 8.8 | 24.6 | 0.005 | 0.98 | 1.4 | NS | 56.8 | 48.8 | NS | 39.7 | 28.6 | NS |
Ref. | No. of studies/period | Type of studies | End point | No. of OLR × LLR | Conversion rate | Favors ORL | Favors LLR | Equal OLR × LLR |
Simillis et al[151] | 8 | Observational | Short-term outcomes | 244 (59.7%) × 165 (40.3%) | 3.7% | Need and duration of portal clamping | Operative blood loss | Blood transfusion rate |
Nonrandomized | Return to oral intake | Operative time | ||||||
Comparative | LOS | Incidence of portal triad clamping | ||||||
1998-2005 | Benign and malignant disease | Adverse events | ||||||
Oncologic clearance | ||||||||
Croome et al[150] | 26 | Observational | Short and long-term outcomes | 1019 (53.9%) × 871 (46.1%) | 3.5% | Lower risk of margins smaller than 1 cm | Operative blood loss | Blood transfusion rate |
Nonrandomized | Return to oral intake | Operative time | ||||||
Comparative | Need for intravenous narcotics | Incidence of portal triad clamping | ||||||
1998-2009 | Benign and malignant disease | Overall complication rate | Oncologic clearance | |||||
All cause mortality in 2-5 yr | Recurrence risk | |||||||
Mirnezami et al[149] | 26 | Observational | Short and long-term outcomes | 961 (57%) × 717 (43%) | 7% | Operative time | Operative blood loss | Portal trial clamping time |
Nonrandomized | Return to oral intake | Margin size | ||||||
Comparative | Overall and specific complications | Hepatic tumor recurrence for HCC | ||||||
1998-2009 | Benign and malignant disease | Incidence of portal triad clamping | DFS for HCC | |||||
Lower risk of margins smaller than 1 cm | ||||||||
Lower rate of positive margins | ||||||||
Increased overall survival for HCC | ||||||||
Zhou et al[118] | 10 | Observational | Short and long-term outcomes | 281 (56.9%) × 213 (43.1%) | 6.1% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Postoperative mortality | ||||||
Comparative | Overall and liver specific complications | Size of resection margins | ||||||
2001-2010 | HCC only | LOS | DFS | |||||
Overall survival | ||||||||
Mizuguchi et al[152] | 11 | Observational | Short-term outcomes | 253 (52.2%) × 232 (47.8%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Postoperative complications | |||||||
Comparative | LOS | |||||||
2001-2008 | Benign and malignant disease | |||||||
Fancellu et al[111] | 9 | Observational | Short and long-term outcomes | 363 (61.5%) × 227 (38.5%) | 4% | - | Rate of positive margins | Liver haemorrhage |
Nonrandomized | Operative blood loss | Bile leakage | ||||||
Comparative | Blood transfusion rate | OS | ||||||
2001-2010 | HCC only | LOS | DFS | |||||
Overall and liver specific complications | ||||||||
Rao et al[94] | 7 | Observational | Short-term outcomes | 111 (45.3%) × 134 (54.7%) | 2.7% | - | Postoperative complications | Operative blood loss |
Nonrandomized | Operative time | Blood transfusion rate | ||||||
2005-2009 | Comparative only patients undergoing laparoscopic × open LLS | LOS | Rate of positive margins | |||||
Li et al[173] | 10 | Observational | Short and long-term outcomes | 383 (61%) × 244 (39%) | 6.6% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Surgical margin size | ||||||
Comparative | Postoperative complications | Rate of positive margins | ||||||
2001-2011 | HCC only | LOS | Tumor recurrence | |||||
Rao et al[148] | 32 | Observational | Short and long-term outcomes | 1305 (52.9%) x 1161 (47.1%) | 2.3% | Operative time | Operative blood loss | Overall and liver specific complications |
Nonrandomized | Blood transfusion rate | Operative mortality | ||||||
Comparative | LOS | Margin width | ||||||
1998-2009 | Benign and malignant disease | Return to oral intake | DFS | |||||
Rate of positive margins | OS | |||||||
Overall complication rate | Recurrence rate | |||||||
Xiong et al[117] | 15 | Observational | Short and long-term outcomes | 316 (57.5%) × 234 (42.5%) | 0% to 19.4% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Pulmonary complications | ||||||
Comparative | LOS | Bleeding | ||||||
2001-2011 | HCC only | Incidence of liver failure and ascites | Bile leakage | |||||
Operative mortality | ||||||||
Rate of positive margins | ||||||||
Tumor recurrence | ||||||||
Rao et al[172] | 10 | Observational | Short-term outcomes | 404 (57.7%) × 296 (42.3%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Ascitis | ||||||
2002-2009 | Comparative | Negative margins rate | Postoperative liver failure | |||||
Malignant tumors | Overall complication rate | DFS | ||||||
LOS | OS | |||||||
Recurrence rate | ||||||||
Yin et al[174] | 15 | Observational | Short and long-term outcomes | 753 (60.8%) × 485 (39.2%) | 2.6% | - | Operative blood loss | Surgical margins |
Nonrandomized | Blood transfusion rate | Operative time | ||||||
Comparative | Postoperative morbidity | Negative margins rate | ||||||
2001-2011 | HCC only | LOS | Recurrence rate | |||||
OS | ||||||||
RFS | ||||||||
Zhou et al[129] | 8 | Observational | Short and long-term outcomes | 427 (61.4%) × 268 (38.6%) | 8.2% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | |||||||
Comparative | Postoperative morbidity | |||||||
2002-2013 | CRLM only | LOS | ||||||
Negative margin | ||||||||
OS | ||||||||
DFS | ||||||||
Twaij et al[168] | 4 | Observational | Short and long-term outcomes | 270 (64.3%) × 150 (35.7%) | 7% to 19.4% | - | Surgical margin size | Operative time |
Nonrandomized | Operative blood loss | OS | ||||||
Comparative | Blood transfusion rate | DFS | ||||||
2009-2013 | HCC only with cirrhosis | Postoperative morbidity | ||||||
Parks et al[167] | 15 | Observational | Short and long-term outcomes | 556 (55.5%) × 446 (44.5%) | 4.2% | - | Operative blood loss | Operative time |
Nonrandomized | LOS | 30-d mortality | ||||||
Comparative | OS | |||||||
2001-2011 | Malignant tumors | |||||||
Luo et al[128] | 7 | Observational | Short and long-term outcomes | 383 (61.4%) × 241 (38.6%) | NR | Margin size | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | LOS | ||||||
Comparative | Postoperative complications | OS | ||||||
2002-2013 | CRLM only | Rate of R1 margins | DFS | |||||
Wei et al[127] | 14 | Observational | Short and long-term outcomes | 599 (61.4%) × 376 (38.6%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Perioperative mortality | ||||||
2002-2013 | Comparative | LOS | OS | |||||
CRLM only | Postoperative complications | DFS | ||||||
13 studies comparing simultaneous | ||||||||
laparoscopic × open resections | 1Simultaneous resection | 1Simultaneous resection | ||||||
LOS | Morbidity, operative time, operative blood loss | |||||||
Schiffman et al[130] | 8 | Observational | Short and long-term outcomes | 368 (60.3%) × 242 (39.7%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Number of major resections | ||||||
Comparative | Overall complication rate | Mean number of resected tumors | ||||||
2009-2013 | CRLM only | LOS | Tumor size | |||||
Positive margins | ||||||||
Margin width | ||||||||
OS | ||||||||
DFS | ||||||||
Jackson et al[153] | 46 | Observational | Short-term outcomes | 1741 (47.8%) × 1901 (52.2%) | 5.68% | Cost | Operative blood loss | Operative time |
Nonrandomized | Negative margin | 30-d mortality | ||||||
2001-2013 | Comparative | LOS | ||||||
Benign and malignant disease | Postoperative complications | |||||||
Morise et al[169] | 21 | Observational | Ascitis | 602 (63.1%) | NR | - | Less ascites | - |
Nonrandomized | × 352 (36.9%) | Less postoperative liver failure | ||||||
2001-2014 | Comparative | |||||||
HCC only | Postoperative liver failure | 220 (54.6%) × 183 (45.7%) |
- Citation: Coelho FF, Kruger JAP, Fonseca GM, Araújo RLC, Jeismann VB, Perini MV, Lupinacci RM, Cecconello I, Herman P. Laparoscopic liver resection: Experience based guidelines. World J Gastrointest Surg 2016; 8(1): 5-26
- URL: https://www.wjgnet.com/1948-9366/full/v8/i1/5.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v8.i1.5